Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease

NCT05811364 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

NCT NCT05811364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05811364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
Lead sponsor
W.L.Gore & Associates
Phase
Not applicable
Overall status
Recruiting
Start date
October 17, 2023
Completion date
January 31, 2032
Enrollment
244 (estimated)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

aortoiliac occlusive disease, peripheral arterial disease